Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate in adults with alkaptonuria and low bone density
NL-OMON28328Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of risedronate in alkaptonuria (AKU), sponsored by University Medical Center Utrecht. Primary endpoints: Change in bone markers, Plasma alkaline phosphatase and 1 more. Started Sep 2005; status: active, not recruiting.
02
Drugs
risedronate
03
Conditions
alkaptonuria (AKU)
Beyond the preview
Go deeper on NL-OMON28328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28328.